atomoxetine hydrochloride has been researched along with Anxiety in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Ciucci, MR; Hoffmeister, JD; Kelm-Nelson, CA | 1 |
| Khan, YS; Khoodoruth, MAS; Ouanes, S | 1 |
| Chaplin, MM; León-Barriera, R; Modesto-Lowe, V; Ortegon, RS | 1 |
| Ballard, R; Janiczak, D; Perez-Reisler, M | 1 |
| Antoniazzi, S; Carnovale, C; Clementi, E; Gentili, M; Nobile, M; Peeters, GGAM; Pozzi, M; Radice, S | 1 |
| Sharma, A | 1 |
| Akita, H; Ishibashi, H; Ogata, M | 1 |
| Hrtanek, I; Kulhan, T; Marcincakova-Husarova, V; Nosalova, G; Ondrejka, I; Snircova, E | 1 |
| Kjar, D; Rajab, MH; Ripperger-Suhler, J; Scott, NG | 1 |
| Clark, CR; Clarke, SD; Cranswick, N; Efron, D; Hermens, DF; Kohn, MR; Lamb, C; Tsang, TW; Williams, LM | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Bernauer, MJ; Farr, AM; Haynes, VS; Kelsey, D; Molife, C | 1 |
| Arnold, LE; Biederman, J; Duesenberg, D; Emslie, GJ; Gao, H; Kratochvil, CJ; Michelson, D; Newcorn, JH; Quintana, H; Sarkis, EH; Wagner, KD | 1 |
4 review(s) available for atomoxetine hydrochloride and Anxiety
| Article | Year |
|---|---|
A systematic review of the use of atomoxetine for management of comorbid anxiety disorders in children and adolescents with attention-deficit hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Anxiety; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Humans; Propylamines; Treatment Outcome | 2022 |
Treating ADHD and Comorbid Anxiety in Children: A Guide for Clinical Practice.
Topics: Adolescent; Anxiety; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Humans | 2023 |
Adverse drug events related to mood and emotion in paediatric patients treated for ADHD: A meta-analysis.
Topics: Affect; Affective Symptoms; Anxiety; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Mood Disorders; Personality Disorders | 2018 |
Update on Common Psychiatric Medications for Children.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Anxiety; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Selective Serotonin Reuptake Inhibitors | 2018 |
3 trial(s) available for atomoxetine hydrochloride and Anxiety
| Article | Year |
|---|---|
Anxiety reduction on atomoxetine and methylphenidate medication in children with ADHD.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Anxiety; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methylphenidate; Retrospective Studies; Treatment Outcome | 2016 |
A randomized controlled trial investigation of a non-stimulant in attention deficit hyperactivity disorder (ACTION): rationale and design.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Affect; Anxiety; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Australia; Child; Cognition; Comorbidity; Cross-Over Studies; Double-Blind Method; Humans; Logistic Models; Neuropsychological Tests; Propylamines; Psychiatric Status Rating Scales; Research Design; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2011 |
Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms.
Topics: Adolescent; Anxiety; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Propylamines; Selective Serotonin Reuptake Inhibitors | 2005 |
6 other study(ies) available for atomoxetine hydrochloride and Anxiety
| Article | Year |
|---|---|
Manipulation of vocal communication and anxiety through pharmacologic modulation of norepinephrine in the Pink1-/- rat model of Parkinson disease.
Topics: Adrenergic Uptake Inhibitors; Animals; Anxiety; Atomoxetine Hydrochloride; Disease Models, Animal; Humans; Male; Norepinephrine; Parkinson Disease; Protein Kinases; Rats; Rats, Long-Evans; Reboxetine; Vocalization, Animal | 2022 |
Diagnosis and Management of Comorbid Anxiety and ADHD in Pediatric Primary Care.
Topics: Anxiety; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Humans; Primary Health Care | 2020 |
Behavioral responses to anxiogenic tasks in young adult rats with neonatal dopamine depletion.
Topics: Adrenergic Uptake Inhibitors; Animals; Animals, Newborn; Anxiety; Atomoxetine Hydrochloride; Behavior, Animal; Dopamine; Dopamine Uptake Inhibitors; Exploratory Behavior; Female; Lighting; Maze Learning; Methamphetamine; Motor Activity; Nerve Net; Oxidopamine; Pregnancy; Rats; Rats, Wistar | 2019 |
Factors associated with atomoxetine efficacy for treatment of attention-deficit/hyperactivity disorder in children and adolescents.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Anxiety; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Depression; Drug Therapy, Combination; Electronic Health Records; Female; Humans; Male; Propylamines; Retrospective Studies; Treatment Outcome | 2010 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Anxiety; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Comorbidity; Depression; Drug Therapy, Combination; Female; Humans; Insurance, Health; Male; Medicaid; Practice Patterns, Physicians'; Propylamines; Retrospective Studies; United States | 2012 |